CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation

Clinical trial NCT00246129 · COMPLETED

Trial details

NCT number: NCT00246129
Sponsor: EMagnusson
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Transplantation Kidney Diseases Kidney Failure

Start date: 2005-10-01
Primary completion: 2011-06-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.